LOG IN
SIGN UP
MARKET
ANGO
ANGO
Angiodynamics
NASDAQ
Real-time Quotes | Nasdaq Last Sale
19.53
+0.43
+2.25%
Opening 11:04 05/27 EDT
OPEN
19.25
PREV CLOSE
19.10
HIGH
19.65
LOW
19.08
VOLUME
25.38K
TURNOVER
378.52K
52 WEEK HIGH
32.00
52 WEEK LOW
17.56
MARKET CAP
757.38M
P/E (TTM)
-19.0351
1D
5D
1M
3M
1Y
5Y
AngioDynamics to Present at the UBS Global Healthcare Conference
LATHAM, N.Y., May 16, 2022--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options, and improving quality of life...
Business Wire · 05/16 20:01
AngioDynamics to Present at the BofA Securities Healthcare Conference
LATHAM, N.Y., May 03, 2022--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options, and improving quality of life...
Business Wire · 05/03 20:01
Swelling losses haven't held back gains for AngioDynamics (NASDAQ:ANGO) shareholders since they're up 35% over 5 years
The main point of investing for the long term is to make money. Better yet, you'd like to see the share price move up...
Simply Wall St. · 05/02 11:02
AngioDynamics (ANGO) Q3 Earnings Top Estimates, Revenues Lag
AngioDynamics (ANGO) registers strong revenue growth in its Med Tech business as well as domestic revenues in third-quarter fiscal 2022.
Zacks · 04/08 14:00
AngioDynamic Fiscal Q3 Sales Trail Estimates Amid COVID-19, Supply Chain Headwinds, Oppenheimer Says
MT Newswires · 04/08 11:31
AngioDynamics Posts Wider Q3 Loss On Higher Costs, Reaffirms FY22 Outlook
Benzinga · 04/07 16:35
AngioDynamics gains despite unchanged guidance as 3Q earnings beat forecasts
The shares AngioDynamics (NASDAQ:ANGO) are trading sharply higher in the morning hours Thursday after the medical device maker reported better than expected earnings for 3Q FY22 despite its unchanged full
Seekingalpha · 04/07 14:26
Sector Update: Health Care
MT Newswires · 04/07 13:45
No Data
Learn about the latest financial forecast of ANGO. Analyze the recent business situations of Angiodynamics through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating
Based on 4 analysts
Buy
Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.
50.00%Strong Buy
0.00%Buy
50.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average ANGO stock price target is 36.00 with a high estimate of 40.00 and a low estimate of 32.00.
Current 19.89
EPS
Actual
Estimate
-0.02-0.010.010.02
- 00
Institutional Holdings
Institutions: 241
Institutional Holdings: 40.69M
% Owned: 104.92%
Shares Outstanding: 38.78M
TypeInstitutionsShares
Increased
49
3.44M
New
10
666.69K
Decreased
67
1.83M
Sold Out
34
990.92K
- Performance
- Asset Allocation
- Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
+1.86%
Healthcare Equipment & Supplies
+2.75%
Key Executives
Non-Executive Chairman/Independent Director
Howard Donnelly
President/Chief Executive Officer/Director
James Clemmer
Chief Financial Officer/Executive Vice President/IR Contact Officer
Stephen Trowbridge
Senior Vice President/General Counsel/Secretary
Richard Rosenzweig
Senior Vice President/General Manager
Chad Campbell
Senior Vice President/General Manager
Scott Centea
Senior Vice President/General Manager
Laura Piccinini
Senior Vice President/Director of Human Resources
Marna Bronfenmoore
Senior Vice President
Benjamin Davis
Senior Vice President
David Helsel
Senior Vice President
Warren Nighan
Other
Juan Serna
Independent Director
Eileen Auen
Independent Director
Wesley Johnson
Independent Director
Karen Licitra
Independent Director
Dennis Meteny
Independent Director
Jan Reed
Independent Director
Michael Tarnoff
No Data
No Data
About ANGO
AngioDynamics, Inc. designs, manufactures and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease, vascular access and for use in oncology and surgical settings. Its devices are used in minimally invasive, image-guided procedures. Its product offerings include Endovascular Therapies, Oncology/Surgery (OS) and Vascular Access (VA). Its Endovascular Therapies product offerings support the medical areas of Thrombus Management, Atherectomy, Peripheral Products (Core) and Venous Insufficiency. Its OS product offerings includes a range of ablation technologies, including thermal tissue ablation systems, surgical resection and the Irreversible Electroporation (IRE) technology, the NanoKnife System. Its portfolio of VA products includes peripherally inserted central catheters (PICCs), midline catheters, implantable ports, dialysis catheters and related accessories and supplies.
Webull offers kinds of AngioDynamics, Inc. stock information, including NASDAQ:ANGO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ANGO stock news, and many more online research tools to help you make informed decisions.
You can practice and explore trading ANGO stock methods without spending real money on the virtual paper trading platform.